KAL Energy Inc.
http://www.kalenergyinc.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From KAL Energy Inc.
Asia Deal Watch: HanAll, Daewoong Team With US Biotech In Parkinson's
Sino acquires Gmax's obesity drug candidate. Simcere partners with Mass General Brigham on select research projects.
Idorsia/J&J’s Aprocitentan Hits Phase III Mark, Could Become First ET-1 Antagonist For Hypertension
The first-in-class ET-1 receptor antagonist has met the primary endpoint in a pivotal resistant hypertension trial, sparking filing plans that could see the drug establish a stronghold in the multi-billion dollar market.
Cancer “Moonshot” Launch Team Announced: Uncomfortable Ties To Anti-Industry Headlines
The Vice President’s cancer “moonshot” is a great opportunity for biopharma companies to engage in a process that should remind policymakers and the public of the promise of biomedical innovation at a time when the industry’s pricing and financial engineering activities are under scrutiny on Capitol Hill. The selection of the “blue ribbon” panel puts those two images in stark contrast.
Vida Healthcare Inc.
Service Carveouts; Disease Managemen; Oncology. Vida Healthcare is positioning itselaf as a "value manager" serving patients, physicians and payers as it seeks to develop local best practices in oncology for physicians, intervene with patients and ultimately develop a body of clinical and outcomes information.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice